Skip to main content

Table 3 The peaks detected by ProteinChip SELDI in patients with hepatocellular carcinoma

From: Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers

Subjects

Protein/Peptide Peaks (m/z)

Type of

Protein Chip

Identification

References

HCV-related HCC

vs. non-HCC

3444, 3890, 4067, 4435, 4470, 7770

CM10

ND

[26]

HCC

vs. non-HCC (cirrhosis)

3687, 3906, 26457

11853, 11873, 11887, 13391

11319, 17783, 17906, 18021

CM10,

IMAC30,

H50,

13391-Da;

Cystatin C

[27]

HBV-related HCC

vs. non-HCC

5890, 11615, 11724

IMAC30-Cu

ND

[28]

CHB

LC

HCC

(vs. Healthy control)

22842 (up), 2957, 2049 (down), 2049 (up), 3166 (down),

23381, 28040 (up),

2018 (down)

WCX2

ND

[29]

HBV-related HCC

vs. Healthy control

7777, 9250, 16200

WCX2

ND

[30]

HCV-related HCC

vs. HCV-related LC

2873, 6646, 7775, 10525,

67867

CM10

6646-Da; Apolipoprotein C-I

[31]

HCV-related HCC

vs. HCV-related LC

22960, 23530

IMAC30

ND

[32]

  1. SELDI; surface-enhanced laser desorption and ionization mass spectrometry, HCV; hepatitis C virus, HCC; hepatocellular carcinoma, HBV; hepatitis B virus, CHB; chronic hepatitis B, LC; liver cirrhosis, ND; not done,